Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaStefan Alig, Ash A. Alizadeh, Charles Macaulay et al.|Journal of Clinical Oncology|2021Cited by 78
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patientsMaria C. Ferrández, Ronald Boellaard, Pieternella J. Lugtenburg et al.|Scientific Reports|2023Cited by 34